Beneficial Changes of Serum Calcification Markers and Contralateral Carotid Plaques Echogenicity after Combined Carotid Artery Stenting Plus Intensive Lipid-lowering Therapy in Patients with Bilateral Carotid Stenosis

European Journal of Vascular and Endovascular Surgery

Volumn 39, Issue 3, 2010, Pages 258-265

  Kadoglou, N P E ^a,b   Gerasimidis, T ^c   Kapelouzou, A ^d   Moumtzouoglou, A ^a   Avgerinos, E D ^b   Kakisis, J D ^b   Karayannacos, P E ^d   Liapis, C D ^b  

^a Aristotle University of Thessaloniki   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Carotid artery stenting; Gray Scale Median; Osteopontin; Osteoprotegerin; Plaque echogenicity; Plaque stability; Statin

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CLOPIDOGREL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOPONTIN; OSTEOPROTEGERIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; B SCAN; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CAROTID PLAQUE ECHOGENICITY; CLINICAL TRIAL; CORRELATION ANALYSIS; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DOWN REGULATION; DRUG DOSE TITRATION; FEMALE; GRAY SCALE MEDIAN SCORE; HUMAN; INTENSIVE CARE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOLOGICAL PARAMETERS; SCORING SYSTEM; TREATMENT OUTCOME;

AGED; ANGIOPLASTY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCINOSIS; CAROTID STENOSIS; COMBINED MODALITY THERAPY; DOWN-REGULATION; FEMALE; GREECE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; OSTEOPONTIN; OSTEOPROTEGERIN; PROSPECTIVE STUDIES; PYRROLES; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER;

EID: 77649272744     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2009.11.013     Document Type: Article

References (32)

1. Effenberger I., Sabeti S., Mlekusch W., Schlager O., Dick P., Puchner S., et al. Increasing carotid plaque echolucency is predictive of cardiovascular events in high-risk patients. Radiology 248 (2008) 1050-1055
2. Lal B.K., Hobson II R.W., Pappas P.J., Kubicka R., Hameed M., Chakhtoura E.Y., et al. Pixel distribution analysis of B-mode ultrasound scan images predicts histologic features of atherosclerotic carotid plaques. J Vasc Surg 35 (2002) 1210-1217
3. Kadoglou N.P., Gerasimidis T., Golemati S., Kapelouzou A., Karayannacos P.E., and Liapis C.D. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability. J Vasc Surg 47 (2008) 55-62
4. Scatena M., Liaw L., and Giachelli C.M. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27 (2007) 2302-2309
5. Golledge J., McCann M., Mangan S., Lam A., and Karan M. Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. Stroke 35 (2004) 1636-1641
6. Kiechl S., Schett G., Wenning G., Redlich K., Oberhollenzer M., Mayr A., et al. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 109 (2004) 2175-2180
7. Kadoglou N.P., Gerasimidis T., Moumtzouoglou A., Kapelouzou A., Sailer N., Fotiadis G., et al. Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis. Eur J Vasc Endovasc Surg 35 (2008) 661-668
8. Athyros V.G., Kakafika A.I., Tziomalos K., Karagiannis A., and Mikhailidis D.P. Pleiotropic effects of statins-clinical evidence. Curr Pharm Des 15 (2009) 479-489
9. Dembowski E., and Davidson M.H. A review of lipid management in primary and secondary prevention. J Cardiopulm Rehabil Prev 29 (2009) 2-12
10. Liapis C.D., Bell P.R., Mikhailidis D., Sivenius J., Nicolaides A., Fernandes e Fernandes J., et al. ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg 37 4 Suppl (2009) 1-19
11. Perler B.A. The effect of statin medications on perioperative and long-term outcomes following carotid endarterectomy or stenting. Semin Vasc Surg 20 (2007) 252-258
12. Bucek R.A., Puchner S., Haumer M., Rand T., Minar E., and Lammer J. Grading of internal carotid artery stenosis: can CTA overcome the confusion?. J Endovasc Ther 13 (2006) 443-450
13. Kadoglou N.P., Iliadis F., Angelopoulou N., Sailer N., Fotiadis G., Voliotis K., et al. Cardiorespiratory capacity is associated with favourable cardiovascular risk profile in patients with Type 2 diabetes. J Diabetes Complications 23 (2009) 160-166
14. Grant E.G., Benson C.B., Moneta G.L., Alexandrov A.V., Baker J.D., Bluth E.I., et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis-Society of Radiologists in Ultrasound Consensus Conference. Radiology 229 (2003) 340-346
15. Griffiths G.D., Razzaq R., Farrell A., Ashleigh R., and Charlesworth D. Variability in measurement of internal carotid artery stenosis by arch angiography and duplex ultrasonography-time for a reappraisal?. Eur J Vasc Endovasc Surg 21 (2001) 130-136
16. Takemoto M., Kitahara M., Yokote K., Asaumi S., Take A., Saito Y., et al. NK-104, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces osteopontin expression by rat aortic smooth muscle cells. Br J Pharmacol 133 (2001) 83-88
17. Garg R., Tellez A., Alviar C., Granada J., Kleiman N.S., and Lev E.I. The effect of percutaneous coronary intervention on inflammatory response and endothelial progenitor cell recruitment. Catheter Cardiovasc Interv 72 (2008) 205-209
18. Lee W.L., Sheu W.H., Liu T.J., Lee W.J., Tsao C.R., Ju Y.H., et al. The short-/intermediate-term changes in novel vascular inflammatory markers after angioplasty plus stenting in patients with symptomatic advanced systemic arterial diseases. Atherosclerosis 176 (2004) 125-132
19. Arauz A., Hoyos L., Zenteno M., Mendoza R., and Alexanderson E. Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron emission tomography. Pilot study. Clin Neurol Neurosurg 109 (2007) 409-412
20. Handberg A., Skjelland M., Michelsen A.E., Sagen E.L., Krohg-Sørensen K., Russell D., et al. Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability. Stroke 39 (2008) 3092-3095
21. Yamagami H., Sakaguchi M., Furukado S., Hoshi T., Abe Y., Hougaku H., et al. Statin therapy increases carotid plaque echogenicity in hypercholesterolemic patients. Ultrasound Med Biol 34 (2008) 1353-1359
22. Spagnoli L.G., Bonanno E., Sangiorgi G., and Mauriello A. Role of inflammation in atherosclerosis. J Nucl Med 48 (2007) 1800-1815
23. Weintraub H.S. Identifying the vulnerable patient with rupture-prone plaque. Am J Cardiol 101 12A (2008) 3F-10F
24. Järvilehto M., and Tuohimaa P. Vasa vasorum hypoxia: initiation of atherosclerosis. Med Hypotheses 73 (2009) 40-41
25. Insull Jr. W. The pathology of atherosclerosis: plaque development and plaque responses to medical treatment. Am J Med 122 1 Suppl (2009) S3-S14
26. Hallow K.M., Taylor W.R., Rachev A., and Vito R.P. Markers of inflammation collocate with increased wall stress in human coronary arterial plaque. Biomech Model Mechanobiol (2009) [Epub ahead of print]
27. Adams G.J., Simoni D.M., Bordelon Jr. C.B., Vick III G.W., Kimball K.T., Insull Jr. W., et al. Bilateral symmetry of human carotid artery atherosclerosis. Stroke 33 (2002) 2575-2580
28. Naylor A.R., John T., Howlett J., Gillespie I., Allan P., and Ruckley C.V. Fate of the non-operated carotid artery after contralateral endarterectomy. Br J Surg 82 (1995) 44-48
29. Fisher M., Paganini-Hill A., Martin A., Cosgrove M., Toole J.F., Barnett H.J., et al. Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis. Stroke 36 (2005) 253-257
30. Ballotta E., Da Giau G., Meneghetti G., Barbon B., Militello C., and Baracchini C. Progression of atherosclerosis in asymptomatic carotid arteries after contralateral endarterectomy: a 10-year prospective study. J Vasc Surg 45 (2007) 516-522
31. Touzé E., Warlow C.P., and Rothwell P.M. Risk of coronary and other nonstroke vascular death in relation to the presence and extent of atherosclerotic disease at the carotid bifurcation. Stroke 37 (2006) 2904-2909
32. Tang T., Howarth S.P., Miller S.R., Trivedi R., Graves M.J., King-Im J.U., et al. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 37 (2006) 2266-2270